Literature DB >> 3338818

Platelet response to aggregated C-reactive protein: fibrinogen-dependent and independent signals.

B A Fiedel1.   

Abstract

Fibrinogen augmented gel-filtered platelet (GFP) aggregation only during an intermediate level of platelet activation stimulated by aggregated C-reactive protein (CRP) (AggCRP), implying that a mechanism to utilize fibrinogen is not operative or does not require an exogenous source of fibrinogen at near-maximal or threshold levels of platelet activation. By contrast, inclusion of the tetrapeptide fibrinogen antagonist, Arg-Gly-Asp-Ser(RGDS), inhibited both intermediate and near-maximal, but not threshold, levels of platelet activation stimulated by AggCRP. These data suggest that AggCRP initially stimulates platelets independent of fibrinogen but, in so doing, activates a fibrinogen-dependent mechanism(s) capable of augmenting the overall extent of platelet stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338818      PMCID: PMC1454700     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

Review 1.  Molecular mechanisms of platelet aggregation.

Authors:  L Leung; R Nachman
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

2.  Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor.

Authors:  B A Fiedel; J N Siegel; H Gewurz; R M Simpson; J M Izzi
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

Review 3.  C-reactive protein and the acute phase response.

Authors:  H Gewurz; C Mold; J Siegel; B Fiedel
Journal:  Adv Intern Med       Date:  1982

4.  Activation of platelets by modified C-reactive protein.

Authors:  B A Fiedel; R M Simpson; H Gewurz
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

5.  Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.

Authors:  R M Simpson; A Prancan; J M Izzi; B A Fiedel
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

6.  Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.

Authors:  D M Haverstick; J F Cowan; K M Yamada; S A Santoro
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

  6 in total
  1 in total

1.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

Authors:  B Shine; J T Bourne; F Begum Baig; J Dacre; D V Doyle
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.